Christopher E. Kubasik - Feb 25, 2022 Form 4 Insider Report for L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)

Role
Vice Chair and CEO, Director
Signature
By: /s/ Michele T. St. Mary, Attorney-in-Fact For: Christopher E. Kubasik
Stock symbol
LHX
Transactions as of
Feb 25, 2022
Transactions value $
$0
Form type
4
Date filed
3/1/2022, 04:45 PM
Previous filing
Feb 28, 2023
Next filing
Mar 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LHX Performance Stock Units Award $0 +48.8K $0.00 48.8K Feb 25, 2022 Common Stock, Par Value $1.00 48.8K $0.00 Direct F1
transaction LHX Non-Qualified Stock Option (Right to Buy) Award $0 +130K $0.00 130K Feb 25, 2022 Common Stock, Par Value $1.00 130K $204.85 Direct F2
transaction LHX Non-Qualified Stock Option (Right to Buy) Award $0 +53.2K $0.00 53.2K Feb 25, 2022 Common Stock, Par Value $1.00 53.2K $233.51 Direct F3
transaction LHX Performance Stock Units Award $0 +24.6K $0.00 24.6K Feb 25, 2022 Common Stock, Par Value $1.00 24.6K $0.00 Direct F4
transaction LHX Restricted Stock Units Award $0 +12.3K $0.00 12.3K Feb 25, 2022 Common Stock, Par Value $1.00 12.3K $0.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 1, 2019, the reporting person was granted performance stock units subject to future vesting and future adjustment, in each case, based on an award payout formula that measures achievement by 12/31/2021 of a target level (with a minimum threshold) for full-year run rate gross synergies from the merger that established L3Harris Technologies, Inc. (the "L3Harris Merger"), with an upward or downward modifier for cumulative earnings per share performance relative to a target. Each performance stock unit represents a contingent right to 1 share of Issuer's common stock, with vested units settled in shares of Issuer's common stock. The maximum level was satisfied, resulting in vesting of the performance stock units at 400% of target, subject to the reporting person's continuing employment through 6/29/2022 (with certain exceptions). The reporting person voluntarily reported the grant of these performance stock units, at target, in a Form 4 filed on 8/5/2019.
F2 On August 1, 2019, the reporting person was granted an option to purchase 129,501 shares of Issuer's common stock subject to future vesting contingent on achievement by 12/31/2021 of a threshold level for full-year run rate gross synergies from the L3Harris Merger. The performance criteria were met, resulting in vesting of the option, subject to the reporting person's continuing employment through 6/29/2022 (with certain exceptions). The reporting person voluntarily reported the grant of this option in a Form 4 filed on 8/5/2019.
F3 Grant of options to purchase shares of Issuer's common stock subject to future vesting and exercisability: 17,740 on first anniversary of grant date, additional 17,741 on second anniversary of grant date and remaining 17,741 on third anniversary of grant date.
F4 Award of performance stock units subject to future vesting on 12/27/2024 in respect of 3-fiscal-year performance period that started January 1, 2022 and also subject to future adjustment based on award payout formula. Each performance stock unit represents a contingent right to 1 share of Issuer's common stock, with vested units settled in shares of Issuer's common stock.
F5 Award of restricted stock units subject to future vesting on 2/25/2025. (Each restricted stock unit represents a contingent right to 1 share of Issuer's common stock.)

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney